In recent years, clinical trials have become increasingly expensive and burdensome to conduct. Technological advances as well as the widespread adoption of electronic health records have provided unique opportunities to streamline and improve clinical research and adapt guidelines to increase regulatory efficiency. The COVID-19 pandemic has challenged the status quo of clinical research and brought into sharp relief current inefficiencies and quality issues. Launched in June 2020, the Good Clinical Trials Collaborative seeks to develop new trial guidelines that support a more efficient regulatory environment and allow researchers to conduct trials that improve patient care. Recent survey findings on how COVID-19 has impacted clinical trials are currently used to inform the development of these new trial guidelines. Join the webinar to learn more about this initiative.

Continuing Education Credits are not offered for this event.